Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Encouraging results reported for Merck anti-HIV combination

Jan. 30, 1997

Triple combination therapy dramatically effective in HIV/AIDS

Jan. 30, 1997

Doxil superior to other treatments for first-line treatment of Kaposi's sarcoma

Jan. 29, 1997

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Jan. 28, 1997

Preliminary results for potential new anti-HIV combination presented

Jan. 28, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...